NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I certainly don't know, but I believe the longer this takes the more likely we get a tumor agnostic label. Certainly if we do, confirming trials will be required to maintain the label, but think how big that would be. I'd also have to believe that a tumor agnostic label wouldn't be possible without the EDEN being approved to make the vaccine. It's one thing to be able to use manual production to handle roughly one third of the new patient population, which is the case with GBM, but if tumor agnostic is authorized, I doubt if we can supply 1% of all new patients manually.

Gary